Notify me when ORBIMED ADVISORS LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 105 | $4,681,973,911 | +$474,714,112 | -$834,221,643 | -$359,507,531 | EWTX, LLY, BSX, EW, UPB | 13F-HR | 17 Feb 2026, 16:17 |
| Q3 2025 | 99 | $4,169,761,714 | +$540,286,652 | -$657,266,422 | -$116,979,770 | EWTX, BSX, LLY, SVA, ELVN | 13F-HR | 14 Nov 2025, 16:12 |
| Q2 2025 | 97 | $3,963,511,824 | +$362,241,763 | -$629,515,045 | -$267,273,282 | SINOVAC BIOTECH LTD, BSX, LLY, EWTX, ELVN | 13F-HR | 14 Aug 2025, 16:36 |
| Q1 2025 | 106 | $4,151,138,893 | +$488,818,033 | -$665,278,862 | -$176,460,829 | SINOVAC BIOTECH LTD, EWTX, BSX, LLY, ELVN | 13F-HR | 15 May 2025, 16:18 |
| Q4 2024 | 111 | $4,798,376,552 | +$615,309,905 | -$779,784,176 | -$164,474,271 | EWTX, SVA, BSX, LLY, ISRG | 13F-HR | 14 Feb 2025, 16:07 |
| Q3 2024 | 109 | $5,464,897,718 | +$605,732,463 | -$641,028,057 | -$35,295,594 | EWTX, SVA, LLY, BSX, ISRG | 13F-HR | 14 Nov 2024, 16:05 |
| Q2 2024 | 108 | $4,658,170,589 | +$363,899,670 | -$623,539,261 | -$259,639,591 | LLY, EWTX, BSX, ISRG, BIIB | 13F-HR | 14 Aug 2024, 16:06 |
| Q1 2024 | 112 | $5,071,082,817 | +$671,334,826 | -$958,489,774 | -$287,154,948 | LLY, EWTX, BSX, ISRG, BIIB | 13F-HR | 15 May 2024, 16:12 |
| Q4 2023 | 109 | $4,992,849,053 | +$461,711,445 | -$836,823,096 | -$375,111,651 | SVA, BIIB, LLY, BSX, ISRG | 13F-HR | 14 Feb 2024, 16:14 |
| Q3 2023 | 120 | $4,321,590,963 | +$549,987,611 | -$717,574,500 | -$167,586,889 | BSX, HUM, ISRG, BIIB, BMRN | 13F-HR | 14 Nov 2023, 16:14 |
| Q2 2023 | 119 | $5,138,527,223 | +$660,275,256 | -$483,654,120 | +$176,621,136 | ISRG, ELVN, BSX, THRX, BIIB | 13F-HR | 14 Aug 2023, 16:25 |
| Q1 2023 | 116 | $5,039,718,413 | +$741,314,485 | -$750,857,834 | -$9,543,349 | SVA, ELVN, BSX, HUM, BMY | 13F-HR | 15 May 2023, 16:41 |
| Q4 2022 | 114 | $4,882,615,389 | +$444,014,030 | -$601,827,023 | -$157,812,993 | UNH, BMY, BSX, HUM, BMRN | 13F-HR | 14 Feb 2023, 16:07 |
| Q3 2022 | 128 | $4,913,427,744 | +$676,577,949 | -$966,862,886 | -$290,284,937 | BMY, HUM, SWTX, BSX, BMRN | 13F-HR | 14 Nov 2022, 16:11 |
| Q2 2022 | 139 | $5,047,194,520 | +$262,932,693 | -$495,587,981 | -$232,655,288 | BMY, HUM, HZNP, BSX, TPTX | 13F-HR | 15 Aug 2022, 16:31 |
| Q1 2022 | 142 | $6,159,428,000 | +$687,681,369 | -$1,089,933,088 | -$402,251,719 | SWTX, HZNP, BSX, PFE, THRX | 13F-HR | 16 May 2022, 16:17 |
| Q4 2021 | 158 | $7,557,095,000 | +$983,104,871 | -$1,179,097,974 | -$195,993,103 | SWTX, BMY, HZNP, BSX, THRX | 13F-HR | 14 Feb 2022, 16:29 |
| Q3 2021 | 167 | $8,755,087,000 | +$1,028,926,214 | -$820,909,024 | +$208,017,190 | SWTX, PRLD, HZNP, MRK, BMY | 13F-HR | 15 Nov 2021, 16:05 |
| Q2 2021 | 156 | $9,698,567,000 | +$958,809,797 | -$636,598,695 | +$322,211,102 | SWTX, BMY, EWTX, BSX, MRK | 13F-HR | 16 Aug 2021, 16:14 |
| Q1 2021 | 153 | $10,171,650,000 | +$2,042,826,518 | -$2,002,998,729 | +$39,827,789 | SWTX, EWTX, PRLD, SPRY, HZNP | 13F-HR | 17 May 2021, 16:16 |
| Q4 2020 | 147 | $11,346,010,000 | +$2,221,718,241 | -$821,209,474 | +$1,400,508,767 | PRLD, SWTX, PMVP, SPRY, ABCL | 13F-HR | 16 Feb 2021, 16:43 |
| Q3 2020 | 140 | $7,831,916,000 | +$1,713,454,491 | -$696,178,058 | +$1,017,276,433 | PRLD, SWTX, PMVP, ALXN, TPTX | 13F-HR | 16 Nov 2020, 16:12 |
| Q2 2020 | 131 | $7,048,166,000 | +$1,101,230,776 | -$1,178,811,571 | -$77,580,795 | SWTX, TCDAQ, ALXN, ASND, PRVL | 13F-HR | 14 Aug 2020, 16:54 |
| Q1 2020 | 138 | $5,907,868,000 | +$1,474,506,456 | -$1,521,375,083 | -$46,868,627 | ASND, TCDAQ, ALEC, SWTX, MRK | 13F-HR | 15 May 2020, 16:25 |
| Q4 2019 | 132 | $6,982,618,000 | +$1,082,548,216 | -$1,055,490,378 | +$27,057,838 | ASND, THOR, TCDAQ, SWTX, PRVL | 13F-HR | 14 Feb 2020, 16:27 |
| Q3 2019 | 108 | $5,217,455,000 | +$523,160,504 | -$986,741,380 | -$463,580,876 | ASND, TCDAQ, BSX, ALEC, PRVL | 13F-HR | 14 Nov 2019, 16:09 |
| Q2 2019 | 119 | $6,337,467,000 | +$886,152,478 | -$954,002,657 | -$67,850,179 | ASND, TCDAQ, BSX, ALXN, ALEC | 13F-HR | 14 Aug 2019, 16:57 |
| Q1 2019 | 117 | $6,379,424,000 | +$1,087,569,921 | -$1,332,633,010 | -$245,063,089 | ASND, TCDAQ, CMTA, ALXN, ALEC | 13F-HR | 15 May 2019, 16:24 |
| Q4 2018 | 125 | $5,357,529,000 | +$654,972,719 | -$2,133,432,228 | -$1,478,459,509 | TCDAQ, ASND, BIIB, CELG, BSX | 13F-HR | 14 Feb 2019, 16:35 |
| Q3 2018 | 146 | $8,271,730,000 | +$1,043,361,321 | -$1,561,775,635 | -$518,414,314 | ALXN, TCDAQ, BIIB, VRTX, BSX | 13F-HR | 14 Nov 2018, 16:07 |
| Q2 2018 | 140 | $8,326,062,000 | +$1,455,992,998 | -$1,462,270,554 | -$6,277,556 | ALXN, BIIB, TCDAQ, BSX, VRTX | 13F-HR | 14 Aug 2018, 16:01 |
| Q1 2018 | 130 | $8,008,642,000 | +$1,749,919,821 | -$1,678,851,202 | +$71,068,619 | ALXN, REGN, VRTX, MRK, BIIB | 13F-HR | 15 May 2018, 16:14 |
| Q4 2017 | 130 | $7,758,285,000 | +$500,796,635 | -$2,622,088,447 | -$2,121,291,812 | BIIB, ALXN, REGN, CELG, VRTX | 13F-HR | 14 Feb 2018, 16:31 |
| Q3 2017 | 136 | $10,406,942,000 | +$1,058,637,648 | -$812,080,703 | +$246,556,945 | ALXN, BIIB, CELG, BSX, MRK | 13F-HR | 14 Nov 2017, 17:19 |
| Q2 2017 | 134 | $9,501,767,000 | +$1,459,856,768 | -$1,218,619,654 | +$241,237,114 | ALXN, CELG, BIIB, BSX, MRK | 13F-HR | 14 Aug 2017, 16:27 |
| Q1 2017 | 131 | $8,787,228,000 | +$1,034,173,665 | -$946,275,970 | +$87,897,695 | ALXN, BIIB, CELG, BSX, MRK | 13F-HR | 15 May 2017, 16:17 |
| Q4 2016 | 128 | $7,792,388,000 | +$1,205,593,243 | -$1,407,436,144 | -$201,842,901 | ALXN, BIIB, CELG, BSX, AMGN | 13F-HR | 14 Feb 2017, 16:25 |
| Q3 2016 | 134 | $8,708,170,000 | +$1,088,442,854 | -$2,600,269,786 | -$1,511,826,932 | BIIB, BSX, AMGN, ALXN, CELG | 13F-HR | 14 Nov 2016, 16:27 |
| Q2 2016 | 132 | $9,477,903,000 | +$1,189,886,909 | -$1,482,425,884 | -$292,538,975 | BSX, AMGN, ABBV, BMY, BIIB | 13F-HR | 15 Aug 2016, 16:16 |
| Q1 2016 | 138 | $9,473,242,000 | +$1,061,239,809 | -$865,342,652 | +$195,897,157 | BMY, HCA, AMGN, BSX, ABBV | 13F-HR | 16 May 2016, 16:20 |
| Q4 2015 | 128 | $11,042,121,000 | +$1,320,319,120 | -$996,681,058 | +$323,638,062 | BMY, AMGN, BSX, AGN, BIIB | 13F-HR | 16 Feb 2016, 16:24 |
| Q3 2015 | 129 | $9,889,044,000 | +$1,117,423,160 | -$1,063,902,522 | +$53,520,638 | BMY, HCA, AMGN, BSX, AGN | Restatement | 18 Nov 2015, 16:02 |
| Q2 2015 | 1 | $1,664,037 | $0 | $0 | $0 | BONE | New Holdings | 20 Aug 2015, 14:30 |
| Q2 2015 | 125 | $11,814,786,037 | +$2,283,423,670 | -$2,061,389,908 | +$222,033,762 | BIIB, BMY, AGN, HCA, ABBV | 13F-HR | 14 Aug 2015, 16:22 |
| Q1 2015 | 125 | $11,453,489,000 | +$1,377,678,372 | -$1,438,921,812 | -$61,243,440 | BMY, BIIB, AMGN, B108PS, CELG | 13F-HR | 15 May 2015, 16:31 |
| Q4 2014 | 121 | $10,297,813,000 | +$1,027,780,207 | -$648,765,815 | +$379,014,392 | BIIB, BMY, AMGN, CELG, GILD | 13F-HR | 13 Feb 2015, 16:13 |
| Q3 2014 | 119 | $8,931,352,000 | +$1,597,188,291 | -$989,423,164 | +$607,765,127 | GILD, BIIB, BMY, AMGN, ICPT | 13F-HR | 14 Nov 2014, 16:15 |
| Q2 2014 | 116 | $8,244,450,000 | +$1,041,383,733 | -$753,178,614 | +$288,205,119 | ICPT, BMY, BIIB, ABBV, GILD | 13F-HR | 14 Aug 2014, 16:23 |
| Q1 2014 | 119 | $7,857,525,000 | +$1,210,081,863 | -$1,020,019,530 | +$190,062,333 | ICPT, GILD, BIIB, BMY, RLYP | 13F-HR | 15 May 2014, 16:26 |
| Q4 2013 | 110 | $6,705,385,000 | $0 | $0 | $0 | GILD, BIIB, CELG, BMY, AMGN | 13F-HR | 14 Feb 2014, 16:25 |